Issue of Equity and Total Voting Rights
RNS Number : 7138X
Bridgepoint Group plc
23 March 2026
Bridgepoint Group plc
("Bridgepoint" or the "Company")
Issue of Equity and Total Voting Rights
Bridgepoint announces that it intends to issue 1,399,733 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards granted in prior years under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.
An application has been made for the admission of the New Ordinary Shares to trading on the LSE's main market for listed securities.
Admission is expected to occur on 26 March 2026.
In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:
| • | 878,071,547 ordinary shares of £0.00005 each with voting rights; and |
| • | 500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights. |
| Analysts and investors Adam Key Adam.Key@bridgepointgroup.com +44 7833 748010 | Media Christian Jones Christian.Jones@bridgepointgroup.com +44 20 7034 3500 |
Recent news on Bridgepoint
See all newsMedia: Bridgepoint weighs $1 billion sale of anti-drone group MyDefence - FT
Spire Healthcare takeover deadline for Toscafund extended to June 25
Brief: T. Rowe Price Associates Holds About 10% Stake In Bridgepoint Group As Of June 4
Holding(s) in Company
Corrected: WRAPUP 2-Partners Group cap fuels fresh concern over private markets